AMERICAN HEALTHCARE REIT INC (AHR) Stock Fundamental Analysis
USA - NYSE:AHR - US3981823038 - REIT
41.05 USD
+0.05 (+0.12%)
41.05 USD
0 (0%)
Taking everything into account, AHR scores 3 out of 10 in our fundamental rating. AHR was compared to 130 industry peers in the Diversified REITs industry. The financial health of AHR is average, but there are quite some concerns on its profitability. AHR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
AHR had negative earnings in the past year.
AHR had a positive operating cash flow in the past year.
1.2 Ratios
With a Return On Assets value of -0.73%, AHR is not doing good in the industry: 62.31% of the companies in the same industry are doing better.
AHR has a Return On Equity of -1.35%. This is in the lower half of the industry: AHR underperforms 61.54% of its industry peers.
AHR's Return On Invested Capital of 3.17% is fine compared to the rest of the industry. AHR outperforms 61.54% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AHR is in line with the industry average of 3.02%.
The last Return On Invested Capital (3.17%) for AHR is above the 3 year average (1.94%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.73% | ||
| ROE | -1.35% | ||
| ROIC | 3.17% |
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
1.3 Margins
AHR has a worse Operating Margin (7.64%) than 81.54% of its industry peers.
In the last couple of years the Operating Margin of AHR has grown nicely.
Looking at the Gross Margin, with a value of 20.62%, AHR is doing worse than 92.31% of the companies in the same industry.
In the last couple of years the Gross Margin of AHR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.64% | ||
| PM (TTM) | N/A | ||
| GM | 20.62% |
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AHR is destroying value.
AHR has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AHR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.09 indicates that AHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
AHR has a better Altman-Z score (2.09) than 95.38% of its industry peers.
The Debt to FCF ratio of AHR is 27.37, which is on the high side as it means it would take AHR, 27.37 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 27.37, AHR is doing good in the industry, outperforming 70.77% of the companies in the same industry.
A Debt/Equity ratio of 0.65 indicates that AHR is somewhat dependend on debt financing.
The Debt to Equity ratio of AHR (0.65) is better than 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 27.37 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.41
WACC7.75%
2.3 Liquidity
AHR has a Current Ratio of 0.85. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
AHR has a Current ratio (0.85) which is comparable to the rest of the industry.
AHR has a Quick Ratio of 0.85. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
AHR's Quick ratio of 0.85 is in line compared to the rest of the industry. AHR outperforms 46.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 58.46% over the past year.
The Revenue has grown by 10.19% in the past year. This is quite good.
AHR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.32% yearly.
EPS 1Y (TTM)58.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1300%
Revenue 1Y (TTM)10.19%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%7.52%
3.2 Future
AHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 79.57% yearly.
The Revenue is expected to grow by 8.13% on average over the next years. This is quite good.
EPS Next Y230.93%
EPS Next 2Y123.44%
EPS Next 3Y79.57%
EPS Next 5YN/A
Revenue Next Year8.67%
Revenue Next 2Y7.91%
Revenue Next 3Y8.13%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AHR. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 50.80, the valuation of AHR can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as AHR.
When comparing the Price/Forward Earnings ratio of AHR to the average of the S&P500 Index (23.21), we can say AHR is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 50.8 |
4.2 Price Multiples
91.54% of the companies in the same industry are cheaper than AHR, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as AHR.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 120.82 | ||
| EV/EBITDA | 24.69 |
4.3 Compensation for Growth
AHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AHR's earnings are expected to grow with 79.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.44%
EPS Next 3Y79.57%
5. Dividend
5.1 Amount
AHR has a Yearly Dividend Yield of 2.42%.
With a Dividend Yield of 2.42, AHR pays less dividend than the industry average, which is at 6.68. 86.15% of the companies listed in the same industry pay a better dividend than AHR!
Compared to an average S&P500 Dividend Yield of 2.44, AHR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.42% |
5.2 History
AHR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
AHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-459.6%
EPS Next 2Y123.44%
EPS Next 3Y79.57%
41.05
+0.05 (+0.12%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners90.78%
Inst Owner Change0%
Ins Owners0.82%
Ins Owner Change1.99%
Market Cap6.92B
Analysts83.75
Price Target47.35 (15.35%)
Short Float %3.44%
Short Ratio3.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.42% |
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP-459.6%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.32%
Min EPS beat(2)33.28%
Max EPS beat(2)71.36%
EPS beat(4)2
Avg EPS beat(4)-137.82%
Min EPS beat(4)-359.9%
Max EPS beat(4)71.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-0.01%
Revenue beat(4)1
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)6.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.93%
PT rev (3m)16.04%
EPS NQ rev (1m)8.14%
EPS NQ rev (3m)27.05%
EPS NY rev (1m)-2.78%
EPS NY rev (3m)-2.78%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 50.8 | ||
| P/S | 3.22 | ||
| P/FCF | 120.82 | ||
| P/OCF | 27.17 | ||
| P/B | 2.86 | ||
| P/tB | 3.41 | ||
| EV/EBITDA | 24.69 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.81
Fwd EY1.97%
FCF(TTM)0.34
FCFY0.83%
OCF(TTM)1.51
OCFY3.68%
SpS12.75
BVpS14.36
TBVpS12.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.73% | ||
| ROE | -1.35% | ||
| ROCE | 4.02% | ||
| ROIC | 3.17% | ||
| ROICexc | 3.28% | ||
| ROICexgc | 3.68% | ||
| OM | 7.64% | ||
| PM (TTM) | N/A | ||
| GM | 20.62% | ||
| FCFM | 2.66% |
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)2.22%
ROICexgc(5y)N/A
ROCE(3y)2.45%
ROCE(5y)N/A
ROICexcg growth 3Y56.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y56.96%
ROICexc growth 5YN/A
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
F-Score7
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 27.37 | ||
| Debt/EBITDA | 4.63 | ||
| Cap/Depr | 113.34% | ||
| Cap/Sales | 9.19% | ||
| Interest Coverage | 1.73 | ||
| Cash Conversion | 75.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 2.09 |
F-Score7
WACC7.75%
ROIC/WACC0.41
Cap/Depr(3y)83.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.98%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1300%
EPS Next Y230.93%
EPS Next 2Y123.44%
EPS Next 3Y79.57%
EPS Next 5YN/A
Revenue 1Y (TTM)10.19%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%7.52%
Revenue Next Year8.67%
Revenue Next 2Y7.91%
Revenue Next 3Y8.13%
Revenue Next 5YN/A
EBIT growth 1Y59.46%
EBIT growth 3Y54.7%
EBIT growth 5YN/A
EBIT Next Year157.32%
EBIT Next 3Y49.12%
EBIT Next 5YN/A
FCF growth 1Y151.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.71%
OCF growth 3Y114.22%
OCF growth 5YN/A